You are here

  • Home
  • Archive
  • Volume 82, Issue 3
  • Comment on: ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al

Article Text

Article menu
Download PDFPDF
Correspondence
Comment on: ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al
  1. Samet Karahan1,
  2. Ali Cetinkaya2,
  3. Kaniye Aydin3,
  4. Hatice Aslan Sirakaya2
  1. 1 Internal Medicine/Rheumatology, Kayseri City Education and Research Hospital, Kayseri, Turkey
  2. 2 Internal Medicine, Kayseri City Education and Research Hospital, Kayseri, Turkey
  3. 3 Internal Medicine/Intensive Care Unit, Kayseri City Education and Research Hospital, Kayseri, Turkey
  1. Correspondence to Dr Samet Karahan, Internal Medicine / Rheumatology, Kayseri City Education and Research Hospital, Kayseri, Turkey; doktorsamet{at}yahoo.com

http://dx.doi.org/10.1136/annrheumdis-2020-218497

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with great interest the article by Gianfrancesco et al concerning characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. In this study, the authors mentioned that glucocorticoid exposure of ≥10 mg/day is associated with higher odds of hospitalisation and antitumour necrosis factor with decreased odds of hospitalisation in patients with rheumatic disease.1 We also aimed to present a case of microscopic polyanitis (MPA) with a diagnostic challenge with COVID-19 pneumonia. A previously healthy man in his 70s, who had complaints of malaise, fever, cough, tachypnea, dyspnoea was admitted to the emergency. Chest CT (CCT) scan revealed peripheral focal ground-glass opacities (GGOs) and infiltrations in the lower and upper lobes on the right and the left middle zones (figure 1). The patient was admitted to the intensive care unit with a prediagnosis of COVID-19 pneumonia and was intubated due to severe acute respiratory failure. Two nasopharyngeal swabs …

    View Full Text

    Footnotes

    • Twitter @doctorsamet

    • Contributors SK: concepts, design, definition of intellectual content, literature search, data acquisition, manuscript preparation and manuscript editing. AC: patient treatment and follow-up. KA: patient treatment and follow-up, manuscript editing, manuscript review. HAS: patient treatment and follow-up.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

    • Provenance and peer review Not commissioned; internally peer reviewed.